Skip navigation
<?php $apdate = '2018-08-17'; $displaydate = 'August 17, 2018'; ?>

Evaluating Roads for Success in a Multi-Stakeholder Forum for Payers, Providers, Pharma and Specialty Pharmacies

October 24-25, 2018
  • Scottsdale, AZ

CBI’s 13th Annual Value Based Oncology Management is a forum for payers to address increasingly important issues surrounding oncology management. As patient care costs rise and new therapies are discovered the need for value-based oncology management is becoming increasingly urgent. Data demonstrates a great deal of underuse and waste in the delivery of cancer care. Adherence to treatment guidelines and quality remain highly variable depending on location, providers and healthcare plans in a wide variety of oncology domains, including end-of-life care, prostate cancer, ovarian cancer, and colorectal cancer screening.

In-Depth Discussions Include:

  • Challenges
  • Best practices and innovations in order to
    increase patient satisfaction
  • Standardize treatments
  • Minimize risk and waste
  • Patient perspective
  • New technologies for diagnostics

Previous Attendee Acclaim:

Extremely timely.

Medical Director, Novant Health

One of the most informative conferences I have been to in years — All the presentations were very relevant to my job.

Medical Director, Blue Cross Blue Shield of Minnesota

The conference was a nice collection of experts discussing their current strategies to improve patient care through systems of care delivery. It was excellent.

US Oncology

13th Annual Value-Based Oncology Management

Evaluating Roads for Success in a Multi-Stakeholder Forum for Payers, Providers, Pharma and Specialty Pharmacies

CBI’s 13th Annual Value Based Oncology Management is a forum for payers to address increasingly important issues surrounding oncology management. As patient care costs rise and new therapies are discovered the need for value-based oncology management is becoming increasingly urgent. Data demonstrates a great deal of underuse and waste in the delivery of cancer care. Adherence to treatment guidelines and quality remain highly variable depending on location, providers and healthcare plans in a wide variety of oncology domains, including end-of-life care, prostate cancer, ovarian cancer, and colorectal cancer screening.

In-Depth Discussions Include:

  • Challenges
  • Best practices and innovations in order to
    increase patient satisfaction
  • Standardize treatments
  • Minimize risk and waste
  • Patient perspective
  • New technologies for diagnostics

Previous Attendee Acclaim:

Extremely timely.

Medical Director, Novant Health

One of the most informative conferences I have been to in years — All the presentations were very relevant to my job.

Medical Director, Blue Cross Blue Shield of Minnesota

The conference was a nice collection of experts discussing their current strategies to improve patient care through systems of care delivery. It was excellent.

US Oncology